Innovative diagnostic techniques and their clinical implications in food allergy: current clinical practice and future perspectives.

IF 3.4 Q2 ALLERGY
Frontiers in allergy Pub Date : 2026-06-10 eCollection Date: 2026-01-01 DOI:10.3389/falgy.2026.1835353
Carlo Maria Rossi, Stefania Merli, Linda Borgonovo, Michelle Giardina, Monarita Yacoub, Baoran Yang, Francesca Losa, Fabio Lodi Rizzini, Serena Nannipieri, Marta Piantanida, Patrizia Pignatti, Donatella Preziosi, Federica Rivolta, Andrea Toniato, Serena Traversi, Alessandro Vrenna, Martina Votto, Antonio Di Sabatino, Vincenzo Patella
{"title":"Innovative diagnostic techniques and their clinical implications in food allergy: current clinical practice and future perspectives.","authors":"Carlo Maria Rossi, Stefania Merli, Linda Borgonovo, Michelle Giardina, Monarita Yacoub, Baoran Yang, Francesca Losa, Fabio Lodi Rizzini, Serena Nannipieri, Marta Piantanida, Patrizia Pignatti, Donatella Preziosi, Federica Rivolta, Andrea Toniato, Serena Traversi, Alessandro Vrenna, Martina Votto, Antonio Di Sabatino, Vincenzo Patella","doi":"10.3389/falgy.2026.1835353","DOIUrl":null,"url":null,"abstract":"<p><p>Food allergy (FA) is an immune-mediated adverse reaction to food components (mainly proteins) and represents an increasing global health problem, affecting millions of individuals and imposing substantial clinical, psychosocial, and economic burdens. Accurate diagnosis is essential to prevent life-threatening reactions while avoiding unnecessary dietary restrictions and impaired quality of life. Current diagnostic approaches rely on clinical history, skin prick tests (SPT), measurement of serum allergen-specific IgE (sIgE), and oral food challenges (OFC). However, SPT and sIgE are highly sensitive but lack specificity, frequently identifying clinically irrelevant sensitization, whereas OFC remains the diagnostic gold standard despite being resource-demanding and carrying a substantial risk of systemic reactions. In recent years, several innovative diagnostic approaches have emerged with the aim of improving diagnostic accuracy and reducing reliance on OFC. Component-resolved diagnostics (CRD) enable detailed characterization of molecular sensitization profiles, supporting improved risk stratification and identification of clinically relevant cross-reactivity patterns. Functional cellular assays, including the basophil activation test (BAT) and the mast cell activation test (MAT), offer direct assessment of IgE-mediated effector cell responses and have demonstrated higher diagnostic specificity compared with conventional testing. Epitope-specific IgE profiling and the allergen-specific IgG4/IgE ratio may additionally contribute to a better understanding of disease phenotype and evolution. Furthermore, advances in multi-omics technologies combined with artificial intelligence and machine learning are creating new opportunities for biomarker discovery and predictive modelling in FA. This narrative review summarizes current innovative diagnostic techniques in food allergy, discussing their clinical applications, limitations, and future directions toward more precise and personalized diagnostic approaches.</p>","PeriodicalId":73062,"journal":{"name":"Frontiers in allergy","volume":"7 ","pages":"1835353"},"PeriodicalIF":3.4000,"publicationDate":"2026-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13290556/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in allergy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/falgy.2026.1835353","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

Abstract

Food allergy (FA) is an immune-mediated adverse reaction to food components (mainly proteins) and represents an increasing global health problem, affecting millions of individuals and imposing substantial clinical, psychosocial, and economic burdens. Accurate diagnosis is essential to prevent life-threatening reactions while avoiding unnecessary dietary restrictions and impaired quality of life. Current diagnostic approaches rely on clinical history, skin prick tests (SPT), measurement of serum allergen-specific IgE (sIgE), and oral food challenges (OFC). However, SPT and sIgE are highly sensitive but lack specificity, frequently identifying clinically irrelevant sensitization, whereas OFC remains the diagnostic gold standard despite being resource-demanding and carrying a substantial risk of systemic reactions. In recent years, several innovative diagnostic approaches have emerged with the aim of improving diagnostic accuracy and reducing reliance on OFC. Component-resolved diagnostics (CRD) enable detailed characterization of molecular sensitization profiles, supporting improved risk stratification and identification of clinically relevant cross-reactivity patterns. Functional cellular assays, including the basophil activation test (BAT) and the mast cell activation test (MAT), offer direct assessment of IgE-mediated effector cell responses and have demonstrated higher diagnostic specificity compared with conventional testing. Epitope-specific IgE profiling and the allergen-specific IgG4/IgE ratio may additionally contribute to a better understanding of disease phenotype and evolution. Furthermore, advances in multi-omics technologies combined with artificial intelligence and machine learning are creating new opportunities for biomarker discovery and predictive modelling in FA. This narrative review summarizes current innovative diagnostic techniques in food allergy, discussing their clinical applications, limitations, and future directions toward more precise and personalized diagnostic approaches.

食物过敏的创新诊断技术及其临床意义:当前临床实践和未来展望。
食物过敏(FA)是一种免疫介导的对食物成分(主要是蛋白质)的不良反应,是一个日益严重的全球健康问题,影响了数百万人,并造成了巨大的临床、社会心理和经济负担。准确的诊断对于预防危及生命的反应,同时避免不必要的饮食限制和生活质量受损至关重要。目前的诊断方法依赖于临床病史、皮肤点刺试验(SPT)、血清过敏原特异性IgE (sIgE)的测量和口腔食物挑战(OFC)。然而,SPT和sIgE是高度敏感的,但缺乏特异性,经常识别临床无关的致敏性,而OFC仍然是诊断的金标准,尽管它需要资源,并且有很大的系统性反应风险。近年来,出现了几种创新的诊断方法,旨在提高诊断准确性和减少对OFC的依赖。组分解析诊断(CRD)能够详细描述分子致敏谱,支持改进的风险分层和临床相关交叉反应模式的识别。功能细胞检测,包括嗜碱性粒细胞激活试验(BAT)和肥大细胞激活试验(MAT),可以直接评估ige介导的效应细胞反应,与传统检测相比,具有更高的诊断特异性。表位特异性IgE谱和过敏原特异性IgG4/IgE比值可能有助于更好地了解疾病表型和进化。此外,与人工智能和机器学习相结合的多组学技术的进步为FA中的生物标志物发现和预测建模创造了新的机会。本文综述了目前在食物过敏方面的创新诊断技术,讨论了它们的临床应用、局限性和未来发展方向,以实现更精确和个性化的诊断方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.80
自引率
0.00%
发文量
0
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书